OKYO PHARMA LIMITED
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 40.77B | ||||||
| 33.21B | ||||||
| 29.36B | ||||||
| 15.7B | ||||||
| 13.08B |
